Literature DB >> 8290824

Pathways of development and progression in bladder cancer: new correlations between clinical observations and molecular mechanisms.

P A Jones1, M J Droller.   

Abstract

Entities:  

Mesh：

Year:  1993        PMID： 8290824

Source DB:  PubMed          Journal:  Semin Urol        ISSN： 0730-9147


× No keyword cloud information.
  13 in total

Review 1.  Classification and grading of the non-invasive urothelial neoplasms: recent advances and controversies.

Authors:  R Montironi; A Lopez-Beltran; R Mazzucchelli; D G Bostwick
Journal:  J Clin Pathol       Date:  2003-02       Impact factor: 3.411

Review 2.  Molecular Characterization of Bladder Cancer.

Authors:  Thenappan Chandrasekar; Annette Erlich; Alexandre R Zlotta
Journal:  Curr Urol Rep       Date:  2018-11-03       Impact factor: 3.092

3.  A Festschrift in Honor of Edward M. Messing, MD, FACS.

Authors:  Jean V Joseph; Ralph Brasacchio; Chunkit Fung; Jay Reeder; Kevin Bylund; Deepak Sahasrabudhe; Shu Yuan Yeh; Ahmed Ghazi; Patrick Fultz; Deborah Rubens; Guan Wu; Eric Singer; Edward Schwarz; Supriya Mohile; James Mohler; Dan Theodorescu; Yi Fen Lee; Paul Okunieff; David McConkey; Hani Rashid; Chawnshang Chang; Yves Fradet; Khurshid Guru; Janet Kukreja; Gerald Sufrin; Yair Lotan; Howard Bailey; Katia Noyes; Seymour Schwartz; Kathy Rideout; Gennady Bratslavsky; Steven C Campbell; Ithaar Derweesh; Per-Anders Abrahamsson; Mark Soloway; Leonard Gomella; Dragan Golijanin; Robert Svatek; Thomas Frye; Seth Lerner; Ganesh Palapattu; George Wilding; Michael Droller; Donald Trump
Journal:  Bladder Cancer       Date:  2018-10-03

4.  Clinical Parameters Outperform Molecular Subtypes for Predicting Outcome in Bladder Cancer: Results from Multiple Cohorts, Including TCGA.

Authors:  Daley S Morera; Sarrah L Hasanali; Daniel Belew; Santu Ghosh; Zachary Klaassen; Andre R Jordan; Jiaojiao Wang; Martha K Terris; Roni J Bollag; Axel S Merseburger; Arnulf Stenzl; Mark S Soloway; Vinata B Lokeshwar
Journal:  J Urol       Date:  2019-05-21       Impact factor: 7.450

Review 5.  Bladder cancer: the molecular progression to invasive disease.

Authors:  A R Simoneau; P A Jones
Journal:  World J Urol       Date:  1994       Impact factor: 4.226

6.  Identification of chromosome 9 alterations and p53 accumulation in isolated carcinoma in situ of the urinary bladder versus carcinoma in situ associated with carcinoma.

Authors:  Anton H N Hopman; Miriam A F Kamps; Ernst J M Speel; Rene F M Schapers; Guido Sauter; Frans C S Ramaekers
Journal:  Am J Pathol       Date:  2002-10       Impact factor: 4.307

7.  Identification of Apo-A1 as a biomarker for early diagnosis of bladder transitional cell carcinoma.

Authors:  Hongjie Li; Changying Li; Huili Wu; Ting Zhang; Jin Wang; Shixin Wang; Jiwu Chang
Journal:  Proteome Sci       Date:  2011-04-17       Impact factor: 2.480

8.  Immunohistochemistry and Fluorescence In Situ Hybridization Can Inform the Differential Diagnosis of Low-Grade Noninvasive Urothelial Carcinoma with an Inverted Growth Pattern and Inverted Urothelial Papilloma.

Authors:  Juan-Juan Sun; Yong Wu; Yong-Ming Lu; Hui-Zhi Zhang; Tao Wang; Xiao-Qun Yang; Meng-Hong Sun; Chao-Fu Wang
Journal:  PLoS One       Date:  2015-07-24       Impact factor: 3.240

9.  Clonality Studies in the Analysis of Adrenal Medullary Proliferations: Application Principles and Limitations.

Authors:  Salvador J. Diaz-Cano
Journal:  Endocr Pathol       Date:  1998       Impact factor: 4.056

Review 10.  Evolution of Urothelial Bladder Cancer in the Context of Molecular Classifications.

Authors:  Martina Minoli; Mirjam Kiener; George N Thalmann; Marianna Kruithof-de Julio; Roland Seiler
Journal:  Int J Mol Sci       Date:  2020-08-07       Impact factor: 5.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.